Today: 3 May 2026

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic closed a $13 billion Series F round in September 2025, setting its post-money valuation at $183 billion. Reuters reports the company is in talks for a new funding round that could push its valuation above $300 billion, though this figure is not confirmed. Anthropic’s revenue run-rate reportedly grew from $1 billion to over $5 billion in 2025, with internal targets as high as $26 billion for 2026.
14 December 2025
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica shares fell nearly 13% Friday, closing at $306.50 on the NYSE and C$421.77 on the TSX, after a broad tech selloff and renewed “AI bubble” concerns. New institutional filings Sunday showed both buying and trimming of positions. Management reaffirmed a $16 billion revenue target and $8.20 adjusted EPS for 2026. RBC and Goldman maintained bullish price targets at $400 and $440, respectively.
14 December 2025
··
Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks announced in August 2025 a Series K funding round valuing the company at over $100 billion. Reuters reported on Nov. 30 that Databricks is in talks to raise $5 billion at a $134 billion valuation, though the company declined to comment. The firm recently surpassed a $4 billion revenue run-rate and reported positive free cash flow. Secondary markets list its valuation at $100 billion as of Dec. 14.
14 December 2025
xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

Elon Musk’s xAI is in advanced talks to raise $15 billion at a reported $230 billion valuation, according to multiple outlets as of December 14, 2025. The distinction between pre- and post-money valuation remains unclear. Musk has publicly disputed some fundraising reports, adding uncertainty. The round is expected to close around December 19.
14 December 2025
··
SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX set its valuation at about $800 billion after approving a secondary share sale at $421 per share, according to a Dec. 12 letter from CFO Bret Johnsen reviewed by Reuters. The deal allows up to $2.56 billion in shares to be sold to investors and SpaceX itself. The company is preparing for a possible IPO in 2026 but has not set a final timeline or valuation.
14 December 2025
·
OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

OpenAI’s latest employee share sale set its valuation at $500 billion this fall. As of December 14, 2025, secondary market data pegs it near $500 billion, while some private trades and proxy estimates suggest figures as high as $600 billion and $750 billion. The company faces scrutiny over whether its business model can sustain mounting infrastructure costs.
14 December 2025
·
Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. shares plunged 34% Friday after its first prospective tenant terminated a $150 million construction funding agreement for Project Matador in West Texas. The company disclosed no funds had been drawn and lease talks continue, but the stock saw record volatility and heavy volume. FRMI closed around $10.09, down sharply from post-IPO highs. Fermi remains pre-revenue and is seeking new tenants for 2026.
14 December 2025
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH shares rose 5.7% Friday to $162.01 after reporting Q3 revenue of $884 million and net income of $36 million, both up 9% year over year. The company’s updated outlook cited ongoing margin pressure from tariffs and international expansion, leading several analysts to cut price targets. RH guided Q4 revenue growth of 7%–8% and an adjusted operating margin of 12.5%–13.5%. Wall Street consensus remains neutral.
14 December 2025
··
CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions authorized a $500 million share repurchase program on Dec. 12, including a $300 million accelerated share repurchase funded by new term-loan borrowings. The company’s Nasdaq ticker changed to “CCC” on Oct. 31. Shares closed at $7.68 on Dec. 14, with a market cap of about $4.93 billion. The ASR with Bank of America is expected to settle by Q2 2026.
14 December 2025
·
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant closed a $550 million stock offering on December 12, 2025, selling 26.2 million shares at $21 each. Roivant Sciences bought 16.7 million shares, investing about $350 million and increasing its stake. IMVT shares ended the week at $26.42, up 6.6% after heavy trading. The company plans to use proceeds to fund clinical trials and general operations.
14 December 2025
·
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics shares closed at $10.55 Friday, up 6.6% after hitting a 52-week high of $10.85. Renewed bullish analyst coverage, including a Zacks “strong buy” and a mean price target of $15.90, followed the move. The company’s profitability trajectory and recent earnings have drawn increased attention from investors.
14 December 2025
··
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon shares jumped 9.6% to $204.97 on Dec. 12 after the company announced CEO Calvin McDonald will step down at the end of January 2026. The leadership change came alongside a Q3 earnings beat, raised 2025 guidance, and a $1 billion buyback increase. LULU is set to exit the Nasdaq-100 index. The stock is down nearly 48% year-to-date.
14 December 2025
··
Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian shares closed Friday, Dec. 12 at $18.42, up about 12% after unveiling its first custom self-driving chip and a new Autonomy+ subscription package. The company is shifting away from Nvidia processors, using chips produced by TSMC. An over-the-air update will expand hands-free driving coverage to 3.5 million miles of U.S. roads. The stock rebounded sharply after initial losses on the autonomy news.
14 December 2025
··
Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure shares closed at $41.08 on Friday, hitting a four-year high after surging in the mid-teens percentage range. The rally followed news of a contract with the Centers for Medicare & Medicaid Services to provide digital identity verification for Medicare.gov, set to launch in early 2026. JPMorgan also upgraded the stock.
14 December 2025
·
Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Polestar’s U.S.-listed shares underwent a 1-for-30 ADS ratio change effective Dec. 9, sending PSNY stock to around $14.33 by Friday amid high volatility. The move, aimed at regaining Nasdaq compliance, did not alter the company’s fundamentals. Polestar reported $2.17 billion in revenue and a $1.56 billion net loss for the first nine months of 2025. Tariffs and U.S. policy uncertainty continue to cloud forecasts.
14 December 2025
·
Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

Destination Greater Victoria will not pursue FIFA World Cup 2026 “overflow dollars” from Vancouver, CEO Paul Nursey told the Times Colonist. The region’s tourism body expects little direct benefit from the event, citing geographic and logistical barriers for visitors crossing to Vancouver Island. Vancouver, meanwhile, is accelerating World Cup preparations, including a citywide fan festival and event programming.
14 December 2025
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer shares closed at $25.85 Friday, Dec. 12, with volume near 50.8 million. The company declared a $0.43 per share dividend for Q1 2026, marking its 349th consecutive payout. New trial data showed Tukysa cut risk of progression or death in HER2+ metastatic breast cancer by about 36%. Investors remain focused on dividend sustainability and pipeline developments.
14 December 2025
··
Oracle Stock (ORCL) News Today: AI Spending Shock, OpenAI Data Center Debate, and Wall Street Forecasts (Dec. 14, 2025)

Oracle Stock (ORCL) News Today: AI Spending Shock, OpenAI Data Center Debate, and Wall Street Forecasts (Dec. 14, 2025)

Oracle shares closed at $189.97 on Friday, down 4.6% after earnings missed guidance and the company announced a $15 billion increase in AI infrastructure spending for fiscal 2026. Credit default swaps on Oracle debt rose sharply. A Bloomberg report on possible OpenAI data center delays pressured the stock, though Oracle denied any impact on contracts. Wall Street price targets were cut but consensus remains a “Moderate Buy.”
14 December 2025
··
Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. shares dropped 33.8% to $10.09 after a prospective tenant canceled a $150 million construction funding deal for Project Matador in Texas. No funds were drawn before termination. Lease negotiations with the tenant continue. At least one analyst cut its price target to $20, while consensus targets remain in the low $30s.
14 December 2025
··
1 … 1,194 1,195 1,196 1,197 1,198 … 1,892

Stock Market Today

  • Kevin Warsh's Fed Transformation Could Challenge Market Expectations
    May 3, 2026, 12:29 AM EDT. Kevin Warsh, likely successor to Jerome Powell as Federal Reserve chair, advocates a tougher stance on inflation, aiming for a strict 2% Personal Consumption Expenditures (PCE) price index target. Unlike Powell's gradual approach, Warsh favors aggressive reduction of the Fed's $6.8 trillion balance sheet, signaling a shift away from cushioning asset prices - often called the 'Fed put.' His approach prioritizes price stability over growth and employment support, potentially allowing slower economic growth and higher unemployment to tame inflation expectations. This new Fed strategy may push Treasury yields higher and pressure growth stocks, unsettling markets used to Fed intervention during downturns.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 03.05.2026

3 May 2026
Rivian shares fell 8.4% to $15.02 after first-quarter results beat expectations, as investors focused on cash burn and profitability concerns. Trading volume jumped 78% above average. The company plans to ramp up R2 SUV production in Georgia to 300,000 units annually. Tesla and Lucid Group shares both rose more than 2%.
Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
Go toTop